問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Find Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
邱泰然
下載
2022-06-01 - 2026-12-31
Condition/Disease
Test Drug
Participate Sites6Sites
Recruiting6Sites
2024-06-30 - 2029-06-30
Participate Sites8Sites
Recruiting8Sites
2024-01-01 - 2027-07-31
Head and Neck Neoplasms
TransCon IL-2 β/γTransCon TLR7/8 Agonist
2024-03-01 - 2028-06-30
Participate Sites5Sites
Recruiting5Sites
2020-05-12 - 2023-12-31
Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
Monalizumab Cetuximab(ErbituxR)
Participate Sites9Sites
Recruiting9Sites
2020-01-01 - 2024-12-31
Breast Cancer or Gastric/Gastroesophageal Junction Adenocarcinoma
ZW25; Tislelizumab (BGB-A317)
Recruiting4Sites
Terminated1Sites
2020-08-01 - 2025-07-01
Locally Advanced or Metastatic Tumors
ABBV-CLS-579
Participate Sites4Sites
Not yet recruiting1Sites
Recruiting3Sites
2023-12-01 - 2027-03-31
Unresectable Metastatic Colorectal Cancer
ABBV-400
Not yet recruiting3Sites
2019-05-01 - 2026-12-31
Advanced Solid Tumors
BA3011
2019-09-01 - 2024-12-31
BA3021
全部
